ACE-031
Unapproved - clinical trials discontinuedResearch compound
Rs. 6,999.00
/ 1mg
Best available evidence
in vitro
preclinical
human pilot
human trial
ACE-031 is a synthetic recombinant fusion protein studied as an ActRIIB / myostatin-pathway research tool. Veracyl supplies it as a reference compound for in vitro and laboratory research only.
Research use only. Not for human or veterinary use. Not a drug, supplement, or food. Not evaluated by any regulatory authority. No dosing or administration guidance is provided.
Research use only
This compound is supplied strictly for in vitro and laboratory research use. It is not for human or veterinary use, not a drug, supplement, or food, and has not been evaluated by any regulatory authority for safety or efficacy. No dosing, administration, or therapeutic guidance is provided.
Evidence stageHuman trial (discontinued)
RegulatoryUnapproved - clinical trials discontinued